Most recently, we have uncovered a SUMO-dependent mechanism that regulates its protein stability and expression in cancer cells23 and a novel phosphorylation of HDAC1 mediated by mitogens, describing a cross-talk between HDAC1 and PI3K pathways with clinical implications towards the treatment of cancer24. This evidence concerns the gene HDAC1 and cancer.